title: False-positive HLA antibody screen associated with Campath administration.
authors.forename: D C
authors.initials: DC
authors.lastname: Lyon
authors.forename: M Y
authors.initials: MY
authors.lastname: Hsu
authors.forename: B W
authors.initials: BW
authors.lastname: Colombe
authors.forename: S K
authors.initials: SK
authors.lastname: Ballas
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000008:administration & dosage* / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000276:immunology; D003429:Cross Reactions; D003951:Diagnostic Errors; D005189:False Positive Reactions; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing / Q000592:standards; D006801:Humans; D007518:Isoantibodies / Q000032:analysis*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D006680:HLA Antigens; D007518:Isoantibodies; D000074323:Alemtuzumab